
Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis
0:00
6:59
The poster was presented by Dr. Lebwohl and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.
This audio commentary is provided by Dr. Steve Feldman.
Flere episoder fra "Research Developments in Atopic Dermatitis"



Gå ikke glip af nogen episoder af “Research Developments in Atopic Dermatitis” - abonnér på podcasten med gratisapp GetPodcast.








